Contrasting Effects of Systemic Monocyte/Macrophage and CD4⁺ T Cell Depletion in a Reversible Ureteral Obstruction Mouse Model of Chronic Kidney Disease

Figure 3

CD11b⁺ and F4/80⁺ cells in kidneys of clodronate-treated or control mice after 6 days of UUO (i.e., day 0 of the rUUO protocol). Representative flow cytometry is shown for CD11b⁺ and F4/80⁺ (a) with data from all kidneys shown graphically (b). Representative immunohistochemical staining for F4/80 is also shown (c). 𝑁=5-6 per group.

(a)

(b)

(c)